[1]
Mahmoud Essam, “Lack of HBV reactivation among patients receiving immunomodulatory drugs in Egyptian cohort who underwent either close monitoring or Preemptive treatment”., J Popl Ther Clin Pharmacol, vol. 30, no. 4, pp. 123–130, Mar. 2023, doi: 10.47750/jptcp.2023.30.04.012.